Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by D. D. Sarbassov
Rictor/mTORC2 Drives Progression and Therapeutic Resistance of HER2-Amplified Breast Cancers
Cancer Research
Cancer Research
Oncology
Role of Insulin-Like Growth Factors and Myogenin in the Altered Program of Proliferation and Differentiation in the NFB4 Mutant Muscle Cell Line.
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Related publications
Her2 Cross Talk and Therapeutic Resistance in Breast Cancer
Frontiers in Bioscience - Landmark
Immunology
Molecular Biology
Biochemistry
Microbiology
Medicine
Genetics
Breast Carcinoma With Amplified HER2: A Gene Expression Signature Specific for Trastuzumab Resistance and Poor Prognosis
Modern Pathology
Forensic Medicine
Pathology
Mechanisms Behind the Resistance to Trastuzumab in HER2-Amplified Breast Cancer and Strategies to Overcome It
Clinical Medicine Insights: Oncology
Oncology
Mechanisms of Resistance to Trastuzumab and Novel Therapeutic Strategies in HER2-Positive Breast Cancer
International Journal of Breast Cancer
Cancer Research
Oncology
Pharmacology
MYC Is Amplified in BRCA1-Associated Breast Cancers
Clinical Cancer Research
Cancer Research
Oncology
Cancer Stem Cell Plasticity Drives Therapeutic Resistance
Cancers
Cancer Research
Oncology
A Phenotypic and Mechanistic Perspective on Heterogeneity of HER2-positive Breast Cancers
Molecular and Cellular Oncology
Cancer Research
Molecular Medicine
Ibrutinib Inhibits ERBB Receptor Tyrosine Kinases and HER2-Amplified Breast Cancer Cell Growth
Molecular Cancer Therapeutics
Cancer Research
Oncology
Identification of New miRNA Biomarkers Associated With HER2-positive Breast Cancers
Oncoscience
Cancer Research
Oncology
